ALX Oncology Holdings Inc. (ALXO)
NASDAQ: ALXO · Real-Time Price · USD
1.960
-0.150 (-7.11%)
Oct 7, 2025, 10:48 AM EDT - Market open
ALX Oncology Holdings Market Cap
ALX Oncology Holdings has a market cap or net worth of $104.96 million as of October 7, 2025. Its market cap has decreased by -8.17% in one year.
Market Cap
104.96M
Enterprise Value
49.86M
1-Year Change
-8.17%
Ranking
Category
Stock Price
$1.96
Market Cap Chart
Since July 17, 2020, ALX Oncology Holdings's market cap has decreased from $1.06B to $104.96M, a decrease of -90.06%. That is a compound annual growth rate of -35.72%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Oct 6, 2025 | 112.99M | 28.28% |
| Dec 31, 2024 | 88.08M | -88.13% |
| Dec 29, 2023 | 741.80M | 61.50% |
| Dec 30, 2022 | 459.31M | -47.23% |
| Dec 31, 2021 | 870.34M | -74.66% |
| Dec 31, 2020 | 3.43B | 225.14% |
| Jul 17, 2020 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Eli Lilly and Company | 760.70B |
| Johnson & Johnson | 451.85B |
| AbbVie | 405.74B |
| UnitedHealth Group | 326.29B |
| Novo Nordisk | 269.41B |
| AstraZeneca | 265.89B |
| Novartis AG | 256.18B |
| Abbott Laboratories | 232.96B |